No Data
Yifeng Pharmacy Chain (603939.SH): There are currently no plans to open retail pharmacies in Hainan.
On December 20, Longzhonghui reported that Yifeng Pharmacy Chain (603939.SH) stated on the interactive platform that the company's Pharmaceutical Retail Trade is currently mainly operated in 10 provinces and cities in Central South, East China, and North China, with the primary customer group being middle-aged and elderly people. There are currently no plans to open retail pharmacies in Hainan.
Sinolink: The end of year centralized purchasing expectations are gradually being cleared, and the pharmaceutical sector行情 is expected to gradually start.
The pharmaceutical Sector is currently in a process of a triple reversal in performance, policies, and funding, with full confidence in the recovery of revenue profit growth and market resurgence of listed companies in the Sector by 2025.
Are Strong Financial Prospects The Force That Is Driving The Momentum In Yifeng Pharmacy Chain Co., Ltd.'s SHSE:603939) Stock?
Sinolink Securities: The favorable wind of medical policies arrives first, followed by innovation going abroad and performance reversal.
In 2025, Sinolink believes that the core investment opportunities in the pharmaceutical Sector will revolve around three main logics: 1) innovation going abroad; 2) demand recovery; 3) reversal of policy expectations.
Yifeng Pharmacy Chain Terminates Share Issuance Plan
Slowing Rates Of Return At Yifeng Pharmacy Chain (SHSE:603939) Leave Little Room For Excitement
Returns Are Gaining Momentum At Yifeng Pharmacy Chain (SHSE:603939)
No Data
